trial
as of 2026-07-01Pharmacy Interventions to Improve Chronic Disease Medication Refill
NCTId NCT00469365
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Completed
Enrollment
3,048 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2006-01
Primary completion
—
Eligibility
ALL
Interventions & indications
Sponsors
Medical University of South CarolinaLead Sponsor
Investigators
2
Paul J Nietert, PhDPrincipal Investigator
Barbara C Tilley, PhDStudy Director
Sites
1 total
Charleston, United States
Facts & assertions
3 sourced
Enrollment
3,048
Phase
PHASE3
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person
person